Key facts
- This page summarizes Kenneth R. Melani's Form 3 filing for Medicus Pharma Ltd. (MDCX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Dec 2024, 16:17.
Kenneth R. Melani - 31 Dec 2024 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MDCX
- Reported as of
- 31 Dec 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Kenneth R. Melani
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Kenneth R. Melani filed Form 3 for Medicus Pharma Ltd. (MDCX) on 31 Dec 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDCX
holding
Common Shares, no par value ("Common Shares")
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,914,330
- Date
- 31 Dec 2024
- Ownership
- See Footnote
- Footnotes
- F1
MDCX
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 409,411
- Date
- 31 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.